Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BLBD | NTLA |
|---|---|---|
| Price | $57.03 | $12.75 |
| Change today | ▲ 0.88% | ▲ 4.00% |
| Market cap | $1.79B | $1.79B |
| Return, 3 months | -28.4% | -26.9% |
| Return, year to date | +21.3% | +41.8% |
| Return, 1 year | +7.4% | -37.9% |
| P/E (TTM) | 6.7 | -3.8 |
| P/B | 2.7 | 2.5 |
| P/E percentile vs own 5y | 40th | 64th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +58.1% | +60.8% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 40 | 57 |
| 30-day volatility | 34.9% | 46.6% |
| Max drawdown, 1 year | -31.9% | -71.3% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
